You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金斯瑞(01548.HK)逆市急弹12%达成协议里程碑事件两附属获付款共5,500万美元
阿思达克 07-29 09:45

金斯瑞生物科技(01548.HK)达成协议里程碑事件,两附属获付款共5,500万美元,该股今早一举升破100天、10天、50天及20天线(17.83-18.68元),最高见20元,现造19.86元,急弹12%,成交达389万股,已超过上周五全日成交量。

金斯瑞生物科技公布,非全资子公司美国传奇及爱尔兰传奇早年与杨森生物科技签署合作及许可协议,根据相关协议,由於美国临床试验的第二个及第三个里程碑事件已经达成,美国传奇及爱尔兰传奇有权就此享有由杨森生物科技分别支付之3,000万美元及2,500万美元之里程碑付款。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account